Synthesis of Amidinohydrazones and Evaluation of Their Inhibitory Effect towards Aldosterone Synthase (CYP11B2) and the Formation of Selected Steroids

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Archiv der Pharmazie

• Publication date

  2004-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/ardp.200400872PMID 15237392
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a test system for inhibitors of human aldosterone synthase (CYP11B2): screening in fission yeast and evaluation of selectivity in V79 cells.

  2002cited by this paper
• Functional expression of human mitochondrial CYP11B2 in fission yeast and identification of a new internal electron transfer protein, etp1.

  2002cited by this paper
• Aldosterone and Myocardial Fibrosis in Heart Failure

  2000cited by this paper
• Induction of cardiac fibrosis by aldosterone.

  2000cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.

  1998cited by this paper
• Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.

  1997cited by this paper
• Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists.

  1996cited by this paper
• The NCI-H295 cell line: a pluripotent model for human adrenocortical studies.

  1994cited by this paper
• Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans.

  1992cited by this paper
• Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis.

  1990cited by this paper
• Potential antisecretory antidiarrheals. 1. Alpha 2-adrenergic aromatic aminoguanidine hydrazones.

  1988cited by this paper

• Emerging trends in small molecule inhibitors targeting aldosterone synthase: A new paradigm in cardiovascular disease treatment.

  2024cites this paper
• Inhibitors of Aldosterone Synthase.

  2019cites this paper
• 4.09 – Toxic Responses of the Adrenal Cortex☆

  2018cites this paper
• Estimation of the Mechanism of Adrenal Action of Endocrine-Disrupting Compounds Using a Computational Model of Adrenal Steroidogenesis in NCI-H295R Cells

  2016cites this paper
• Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases.

  2014cites this paper
• Toxic Responses of the Adrenal Cortex

  2010cites this paper
• Aldosterone synthase inhibitors: pharmacological and clinical aspects.

  2009cites this paper
• Coexpression of CYP11B2 or CYP11B1 with adrenodoxin and adrenodoxin reductase for assessing the potency and selectivity of aldosterone synthase inhibitors.

  2009cites this paper
• Synthesis, Characterization, and Antitumor Activity of Some Metal Complexes with Schiff Bases Derived from 9-Fluorenone as a Polycyclic Aromatic Compound

  2008cites this paper
• Adrenal toxicology: a strategy for assessment of functional toxicity to the adrenal cortex and steroidogenesis

  2007influential citation
• Synthesis and evaluation of heteroaryl-substituted dihydronaphthalenes and indenes: potent and selective inhibitors of aldosterone synthase (CYP11B2) for the treatment of congestive heart failure and myocardial fibrosis.

  2006cites this paper
• Synthesis and evaluation of selective inhibitors of aldosterone synthase (CYP11B2) of the naphthalene and dihydronaphthalene type for the treatment of congestive heart failure and myocardial fibrosis

  2006cites this paper
• The adrenocortical tumor cell line NCI-H295R as an in vitro screening system for the evaluation of CYP11B2 (aldosterone synthase) and CYP11B1 (steroid-11beta-hydroxylase) inhibitors.

  2005cites this paper